249 related articles for article (PubMed ID: 18087043)
1. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.
DeLuca GC; Ramagopalan SV; Herrera BM; Dyment DA; Lincoln MR; Montpetit A; Pugliatti M; Barnardo MC; Risch NJ; Sadovnick AD; Chao M; Sotgiu S; Hudson TJ; Ebers GC
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20896-901. PubMed ID: 18087043
[TBL] [Abstract][Full Text] [Related]
2. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
[TBL] [Abstract][Full Text] [Related]
3. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
[TBL] [Abstract][Full Text] [Related]
4. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
5. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
Handel AE; De Luca GC; Morahan J; Handunnetthi L; Sadovnick AD; Ebers GC; Ramagopalan SV
J Neuroimmunol; 2010 Jun; 223(1-2):120-3. PubMed ID: 20394989
[TBL] [Abstract][Full Text] [Related]
6. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
Chao MJ; Barnardo MC; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Montpetit A; Sadovnick AD; Knight JC; Ebers GC
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13069-74. PubMed ID: 18765817
[TBL] [Abstract][Full Text] [Related]
7. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
[TBL] [Abstract][Full Text] [Related]
8. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene.
Ramagopalan SV; McMahon R; Dyment DA; Sadovnick AD; Ebers GC; Wittkowski KM
BMC Med Genet; 2009 Feb; 10():10. PubMed ID: 19193207
[TBL] [Abstract][Full Text] [Related]
9. Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.
Cree BA; Reich DE; Khan O; De Jager PL; Nakashima I; Takahashi T; Bar-Or A; Tong C; Hauser SL; Oksenberg JR
Arch Neurol; 2009 Feb; 66(2):226-33. PubMed ID: 19204159
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
11. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
12. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
14. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
15. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J
Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906
[TBL] [Abstract][Full Text] [Related]
16. Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Cutter G; Tamaño-Blanco M; Marr K; Badgett D; Carl E; Elfadil M; Kennedy C; Benedict RH; Ramanathan M
PLoS One; 2011 Feb; 6(2):e16802. PubMed ID: 21340025
[TBL] [Abstract][Full Text] [Related]
17. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
18. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Ramagopalan SV; Maugeri NJ; Handunnetthi L; Lincoln MR; Orton SM; Dyment DA; Deluca GC; Herrera BM; Chao MJ; Sadovnick AD; Ebers GC; Knight JC
PLoS Genet; 2009 Feb; 5(2):e1000369. PubMed ID: 19197344
[TBL] [Abstract][Full Text] [Related]
19. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
20. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
Zhang Q; Lin CY; Dong Q; Wang J; Wang W
Autoimmun Rev; 2011 Jun; 10(8):474-81. PubMed ID: 21440682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
